Overview

Update
Investments
126 Investments in 72 Companies
Exits
6 IPOs & 17 Acquisitions
Headquarters:
Boston, MA
Funds Raised:
$1.82B
Categories:
Medical Device, Health Care, Biotechnology
Description:
SV Life Sciences is a Boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Website:
http://www.svlsa.com
Social:

Investor Details

Update

SV Life Sciences is a venture capital adviser and manager that makes selected investments in entrepreneurs and management teams.

SV Life Sciences provides finance to businesses at all stages of development and across the human life sciences sector. These sectors range from biotechnology & pharmaceuticals to medical devices & instruments, to healthcare information technology and services. SV Life Sciences currently advises or manages five funds with capital commitments of approximately $1.5 billion which primarily invest amounts of between $1m and $40m in North America and Europe, but will consider innovative investments in other regions. Our team of 34 professionals has a diverse, complimentary set of skills and experience that allow us to tailor a team to work with almost any life sciences business.

Acquisitions (1)

Update
DateAcquiredAmount
Nov 5, 2014Unknown
DateInvested InRoundPartner(s)
Sep, 2016£25M / Series A (Lead)
Aug, 2016$25M / Series A (Lead)
Aug, 2016$11.89M / Series A (Lead) and
Jul, 2016$32M / Series C
May, 2016$23.88M / Series B
Jan, 2016$15M / Series B
Aug, 2015$38M / Series D
Aug, 2015$7.6M / Series C
Jul, 2015$33M / Series B
Jul, 2015£8M / Series A
Apr, 2015$20M / Venture
Jan, 2015$12.4M / Series A (Lead)
Dec, 2014$50M / Series F
Oct, 2014$32M / Series A
Sep, 2014$21M / Venture
Jun, 2014$34M / Venture (Lead)
May, 2014$2.38M / Debt Financing
Feb, 2014$49M / Series B
Jan, 2014$43.6M / Series D
Jan, 2014£4.5M / Venture
Dec, 2013undisclosed amount / Series A
Dec, 2013$16M / Series C
Dec, 2013$26M / Series D
Nov, 2013£17M / Series A
Nov, 2013$32.4M / Series B
Nov, 2013$8M / Series A
Sep, 2013$11.9M / Debt Financing
Sep, 2013$20M / Series B
Jul, 2013$19M / Series B (Lead)
Mar, 2013$23M / Series E
Feb, 2013$9M / Venture
Jan, 2013$23.8M / Series D
Dec, 2012£3.75M / Undisclosed
Oct, 2012undisclosed amount / Venture
Oct, 2012$15M / Series C
Oct, 2012$10M / Series A (Lead)
Sep, 2012$7.6M / Series B
Jul, 2012$7.29M / Venture
May, 2012$16.5M / Series C
Apr, 2012$14M / Venture

Current Team (32)

Update

Funds (6)

Update
AnnouncedNameAmount
Unknown DateLife Sciences Fund V$523M
Jun 4, 2003International Life Sciences Fund III$402M
May 26, 2015SV Life Sciences Fund VIUnknown Amount
Unknown DateSixth Health-care Fund$525M
May 27, 2016SV Life Sciences Fund VI$273.5M
Oct 21, 2015Dementia Discovery Fund$100M

Offices/Locations (3)

Update
  • Headquarters

    One Boston Place

    201 Washington Street, Suite 3900

    Boston, MA 02108

    USA

  • California Office

    1700 Owens Street

    Suite 184

    San Francisco, CA 94158

    USA

  • London Office

    71 Kingsway

    London, WC2B 6ST

    GBR

Add Board Members and Advisors

Add Competitors

Add Memberships

Add Images

Add Videos